Takeda Pharmaceutical Company Limited (TAK) Stock Price

18.52 ▲ +0.25 (+1.37%)
Open: 18.22 Vol: 4.95M Day's range: 18.20 - 18.585 Mar 31, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TAK Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 18.52▼ 18.46▲ 18.44▲ 18.21▲ 17.98▲
MA10 18.49▲ 18.42▲ 18.37▲ 18.09▲ 18.09▲
MA20 18.46▲ 18.35▲ 18.24▲ 18.07▲ 16.65▲
MA50 18.44▲ 18.22▲ 18.15▲ 17.87▲ 15.45▲
MA100 18.37▲ 18.13▲ 18.10▲ 16.35▲ 14.66▲
MA200 18.26▲ 18.10▲ 18.21▲ 15.51▲ 14.73▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.008▲ 0.009▲ 0.028▲ 0.004▲ 0.105▲
RSI 62.335▲ 70.345▲ 69.048▲ 58.600▲ 70.573▲
STOCH 90.673▲ 55.408     72.624     56.253     74.377    
WILL %R -24.138▲ -17.500▲ -16.092▲ -7.692▲ -8.982▲
CCI 84.740     134.770▲ 140.928▲ 137.481▲ 70.470    
Latest Filters Detected On TAK
▲ RSI&MACD $TAK MACD cross and RSI above 55 Set Alert
▲ MACD $TAK MACD(12,26,9) Crossed Above Signal Line Set Alert
▲ BREAK $TAK Price Breaks 20 Days High Set Alert
▲ BREAK $TAK Price Breaks 10 Days High Set Alert
Takeda Pharmaceutical Company Limited News
Takeda Pharmaceutical Showcases Strong Phase III Psoriasis Data for Zasocitinib, Eyes 2027 Launch
Saturday, March 28, 2026 07:29 PM
Takeda Pharmaceutical (NYSE:TAK) highlighted late-breaking Phase III data for investigational TYK2 inhibitor zasocitinib in moderate-to-severe plaque psoriasis and outlined its commercial plans during ...
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
Saturday, March 28, 2026 12:25 PM
Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...
FDA Grants Priority Review for Takeda (TAK) and Protagonist’s Rusfertide in PV Treatment
Sunday, March 08, 2026 09:01 AM
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the most promising stocks under $20. On March 2, Takeda and Protagonist Therapeutics announced that the US FDA accepted the New Drug ...
TAK historical stock data
date open high low close volume
31/03/26 18.22 18.585 18.20 18.52 4,945,226
30/03/26 18.20 18.34 18.14 18.27 3,134,777
27/03/26 18.00 18.19 17.87 17.91 2,255,181
26/03/26 18.09 18.265 18.035 18.06 2,245,111
25/03/26 18.37 18.39 18.23 18.29 2,675,000
24/03/26 17.79 18.115 17.78 18.04 3,251,372
23/03/26 17.94 17.985 17.785 17.86 3,227,688
20/03/26 18.12 18.12 17.7823 17.83 2,462,510
19/03/26 17.98 18.20 17.98 18.11 2,521,028
18/03/26 18.30 18.31 17.985 18.03 3,158,872
Quote Details
52wk Low:12.99
52wk High:18.82
Vol:4.95M
Avg Vol(3m):59.6M
1Y Chng:+26.42%
1M Chng:-0.11%
Add to Watch List
More Information
Index N/A
Market Cap. 57.72B